Last data update: Nov 30, 2022. (Total: 4113 publications since 2011)
|Query Trace: all>>Bo-Hyun Cho[CDC Author]|
| Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.
Miwako Kobayashi, Charles Stoecker, Wei Xing, Bo-Hyun Cho, and Tamara Pilishvili
Human vaccines & immunotherapeutics 2021 Jan 1-9
Similar articles in PubMed DOI:10.1080/21645515.2020.1861876
| School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.
Ricardo Basurto-Dávila, Martin I Meltzer, Dora A Mills, Garrett R Beeler Asay, Bo-Hyun Cho, Samuel B Graitcer, Nancy L Dube, Mark G Thompson, Suchita A Patel, Samuel K Peasah, Jill M Ferdinands, Paul Gargiullo, Mark Messonnier, and David K Shay
Health services research 2017 52 Suppl 22307-2330
Similar articles in PubMed DOI:10.1111/1475-6773.12786